Search
Search Constraints
You searched for: Author/Creator Bennett, Hamilton- Bennett, Hamilton [remove] 5
- 572 3
- Bioorganic chemistry -- Periodicals 3
- Pharmaceutical chemistry -- Periodicals 3
- 615.372 2
- Vaccines -- Periodicals 2
- ACE2 angiotensin-converting enzyme 2 -- ELISA enzyme-linked immunosorbent assay -- GMT geometric mean titer -- ID50 inhibitory dilution factor -- IgG immunoglobulin G -- LNP lipid nanoparticle -- Nab neutralizing antibody -- NHPs non-human primates -- ns not significant -- NTD N-terminal domain -- PBS phosphate-buffered saline -- PsVN pseudovirus neutralization titer -- RBD receptor binding domain -- RLUs relative luminescence units -- S spike -- SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 -- TMB tetramethylbenzidine -- UTR untranslated region -- VOC variant of concern -- VOI variant of interest -- VSV vesicular stomatitis virus 1
- AE adverse event -- ARs adverse reaction -- bAb serum binding antibody -- CoV coronaviruses -- COVID-19 coronavirus disease 2019 -- CRO clinical research organization -- eDiary electronic diary -- ELISA enzyme-linked immunosorbent assay -- LLOQ lower limit of quantification -- MAAE medically-attended adverse event -- MN microneutralization -- mRNA messenger ribonucleic acid -- nAb serum neutralizing antibody -- RT-PCR reverse transcription polymerase chain reaction -- SAE serious adverse event -- SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 -- ULOQ upper limit of quantification 1
- COVID-19 -- SARS-CoV-2 variants of concern -- mRNA-1273 -- Primary series -- Booster dose -- Neutralization 1
- Isostere -- Influenza -- VX-787 1
- SARS-CoV-2 -- COVID-19 -- mRNA-1273 -- Phase 2 -- Vaccine -- Safety -- Immunogenicity 1